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Abstract: Integrated electrochemical reactors in automated flow systems have 
been utilised for selenenylation reactions. The automation has allowed to 
perform multiple electrochemical reactions of a programmed sequence in a 
fully autonomous way. Many functionalised selenenylated products have been 
synthesised in short reaction time with good to high yields.  
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There has been large efforts in developing technologies in 
organic synthesis to enhance product output in shorter time.1 
Continuous flow syntheses2 and electrochemical reactions3 have 
played a significant role in this development. These areas of 
research are still actively pursued in academia and industry. We 
have designed and manufactured an electrochemical flow 
microreactor device to improve the efficiency of electrochemical 
flow reactions integrated with inline mass spectrometric 
analysis. 4  A much improved device is now commercially 
available.5 The advantage of being able to remotely control flow 
electrochemical equipment is demonstrated here with its 
inclusion in a fully automated flow setup. In continuation of our 
efforts in the development of tools and techniques we apply 
electrochemistry in the selenenylation of alkenes as a modular 
reaction. In the automated setup, the starting alkene, the 
diselenide as selenenylating reagent and the nucleophile can be 
selected. Different combinations will lead to different product 
solutions, which can be collected separately. The automated 
sequence of different reactions with integrated cleaning cycles 
allows an independent operation of many reactions, which is only 
limited by the number of available collection vials. A schematic 
representation of this system is shown in Figure 1. Automation 
has the potential to reduce the necessary manpower, avoiding 
human errors, and has a positive contribution towards 
sustainable and green chemistry by minimizing waste.6 
 
Figure 1. Automated selenenylations in flow electrochemistry. 
 
Organoselenium compounds are interesting molecules owing to 
their importance in medicinal chemistry, material chemistry and 
as reagents and catalysts.7 We have investigated many different 
aspects of selenium chemistry in the past including some batch 
electrochemical transformations. 8  Addition of selenium 
electrophiles to alkenes in the presence of nucleophiles is a 
general concept to access β-substituted selenides utilizing 
different reaction conditions and types of oxidants to access the 
selenium electrophiles. As an efficient and environmentally 
friendly protocol for organic synthesis, electrochemical 
conversions have gained more and more attention as often an 
excess amount of conventional chemical oxidants and reducing 
reagents can be avoided. 9  The synthesis of β-substituted 
selenides electrochemically is a very promising approach as 
shown also in recent publications.10 These methods are efficient 
but still require a lot of effort to develop robust reliable reaction 
conditions. We describe the use of an automated electrochemical 
flow system for the synthesis of different β-substituted selenides 
in a continuous process. To the best of our knowledge, this is the 
first use of a flow electrochemical reactor integrated in an 
automated system.  
We initiated our studies to identify optimal reaction conditions in 
the three component reaction using alkenes, diphenyl diselenide 
and different alcohols as nucleophiles (Scheme 1). We use a 
Vapourtec automated flow system with the integrated Ion 
electrochemical microflow reactor to rapidly and automatically 
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screen different reaction variables. The software allowed a setup 
of a number of reactions applying different reaction conditions 
and collecting the individual reaction products in an automated 
way even during overnight operation. 
 
Scheme 1. Selenenylation of alkenes. 
As a model reaction, styrene (0.15 M), diphenyl diselenide (0.05 
M) and CH3OH (30 equiv) in CH3CN were reacted using graphite 
(Gr) as anode and platinum (Pt) as cathode with a flow rate of 0.1 
mL min−1 and 5 mM tetrabutylammonium tetrafluoroborate 
(Bu4NBF4) as the supporting electrolyte. With a residence time of 
6 minutes and a current of 16 mA (2.0 F) at room temperature, 
only 32% of the desired product 4 was obtained. Theoretically, 
only 2.0 F electricity is required for the two-electron oxidation. 
However, it was observed that increasing current from 16 mA to 
32 mA (4 F) increases the yield from 32% to 66% with recovery 
of starting materials. A further increase of the current beyond 4.0 
F led to a decrease of the yield of the desired product 4.  
Different parameters for the flow electrochemical reactions were 
studied such as solvents, electrolytes, flow rates and electrode 
materials. Different solvents and solvent mixtures such as 
acetonitrile, tetrahydrofuran, methanol and mixtures of 
acetonitrile/tetrahydrofuran were screened. It was found that 
acetonitrile was the optimal solvent for this reaction (see 
supporting information). Lei and co-authors reported an 
oxyselenenylation using styrene in a batch electrochemical 
process using stoichiometric amounts of tetrabutylammonium 
tetrafluoroborate (Bu4NBF4) as a supporting electrolyte.10b We 
discovered that under flow conditions only catalytic amounts of 
Bu4NBF4 were necessary to obtain identical results in a shorter 
reaction time. Without any addition of electrolyte, the reaction in 
the electrochemical flow reactor still led to a yield of 32%. The 
presence of electrolyte has a significant influence on the yield. 
Different electrolytes such as Bu4NBF4, Bu4NOTs, Et4NCl, Bu4NBr, 
KI and Bu4NI were screened in catalytic amounts and Bu4NI 
showed the highest yield of 87% (see supporting information). 
From cyclic voltammetry studies (see supporting information) 
we presume that iodide is oxidised at the anode sequentially from 
iodide to the iodine radical to iodine cation: I− → I• → I+.10c The 
iodine cation is known to activate the diselenide by generating 
PhSeI and another reactive PhSe+ that reacts to the desired 
product.  
The effect of flow rate/residence time on product yield were 
studied as to determine the optimal flow rate in order to avoid 
mass-transfer limitations.11 Surprisingly, increasing the flow rate 
to 0.2 - 0.4 mL min–1 led to full conversion with >99% yield. A 
further increase to flow rates above 0.4 mL min–1 resulted in a 
drop in yield. It may be due to a decreased conductivity at higher 
flow rates. An increase of the electrolyte concentration from 5 
mM to 7.5 mM allowed to obtain again quantitative yield at flow 
rates up to 0.6 mL min–1 corresponding to a calculated residence 
time of 1.0 minutes (see supporting information). Due to the 
formation of hydrogen the actual residence time is lower. The 
increase in electrolyte concentration allowed a further reduction 
of the reaction time. 
Also different electrode materials were screened4 (see 
supporting information). Initially, platinum (Pt) was used as 
cathode and different anode materials such as graphite (Gr), 
glassy carbon (GC), boron-doped diamond (BDD), Panasonic 
carbon, PTFE carbon, stainless steel (Fe) and nickel (Ni) were 
screened. Among these, Gr as anode was found to be most 
efficient. Furthermore, Gr as anode was then screened against 
various cathodes such as Pt loaded on Nb, Pt loaded on Ti, Ni, Fe, 
Gr, GC and Zn. From this screening it was found that Gr as anode 
and Pt as cathode were an optimal combination. A low-cost 
electrode (Pt loaded on Nb) still gave 95% yield. The same trend 
was observed for Gr as a cathode and anode. 
With the optimised reaction conditions in hand, an investigation 
of the scope and general applicability of this methodology using 
different alkenes, alcohols and diselenides was performed in an 
automated way. Loading different alkenes, alcohols and 
diselenides into the autosampler allowed the reaction products 
shown in Schemes 2, 3 and Figure 2 to be obtained in a fully 
automated way without additional manual interference. The 
different product solutions obtained were purified using a 
Biotage Isolera chromatography system. Due to the automated 
protocol, all reactions shown have been performed using 
identical amounts and concentrations of reagents and 1.2 mmol 
alkene have been used in each experiment. 
 
Scheme 2. Scope and limitation for electrochemical methoxyselenenylations 
of alkenes. [a] Dibenzyl diselenide used instead of diphenyl diselenide. 
Pleasingly, the electrochemical reaction of many different 
substituted styrene derivatives gave the desired products 4 – 27 
in good to excellent yields except for 24 and 25, where the 
disubstituted alkenes did not lead to any product formation. 
Alkyl-substituted alkenes lead, as known, to regioisomeric 
mixtures (28 – 30). While 3,4-dihydro-2H-pyran formed product 
32 in 14% yield as the only regioisomer but, as reported, in a 1:1 
(cis:trans) mixture,12 indole was selenenylated in the 3-position 
leading to 33. 13  Also other diselenides such as dibenzyl 




diselenide can be used as demonstrated in the synthesis of 34, 
where CH3CN and THF as a solvent mixture (1:1) were used. 
Variations of nucleophiles in the selenenylation are shown in 
Scheme 3. Primary, secondary and tertiary alcohols can be used 
in the selenenylation reactions as shown in the formation of 
products 35 – 45. Even water, formic acid and acetic acid can be 
used and products 46 – 48 are obtained. Benzotriazole as an N-
nucleophile participated in this reaction to form the 
aminoselenenylated product 49 in 65% yield. 
 
Scheme 3. Different nucleophiles for the electrochemical selenenylation of 
styrene. 
Cyclic ethers and lactones are important cores in several natural 
products and important bioactive molecules. This methodology 
can also be expanded to intramolecular cyclizations and was 
found to be efficient to obtain a variety of cyclised O-heterocycles 
as shown in Figure 2. The lactones and ethers were obtained in 
moderate to good yields. Furan such as 50 was obtained in 73% 
yield. Functionalised pyrans 51 and 52 were obtained in 67 and 
58% yield, respectively. Different functionalised and fused 
lactones 53 – 56 were obtained in good yields. Similarly, 
dihydroindole 57 was synthesised and was obtained in 33% 
yield. All the synthesised compounds were fully characterised 
using different spectroscopic techniques. Among them, also a 
single crystal x-ray analysis was performed for compound 21 
(see supporting information) that further supports the formation 
of the target molecules and the spectroscopic data. 14  The 
selenium cation necessary for the addition and cyclisation 
reactions described here is believed to be formed through 
sequential oxidation of diphenyl diselenide as already 
investigated by Breder, Siewert and coworkers.10d The oxidation 
potential required for a subsequent elimination of the selenide is 
not reached here. 
 
Figure 2. Electrochemical selenocyclisations. 
To further demonstrate the synthetic potential of this protocol, a 
gram scale reaction was performed for the synthesis of product 
4. 1.52 g of 4 was synthesised in 100 minutes corresponding to 
87% yield. 
In summary, we have demonstrated that electrochemical 
reactions such as selenenylations of alkenes can be easily 
integrated in remote-controlled synthesis equipment allowing an 
automated synthesis of many derivatives in a short time with 
minimal human interference. A library of 54 molecules of alkoxy 
and aza-selenenylations have been synthesised including 
intramolecular reactions for the synthesis of heterocyclic 
compounds. A gram scale reaction was also performed to 
demonstrate the potential of this electrochemically integrated 
automated flow technology. 
The experimental section has no title; please leave this line here. 
All solvents and reagents were used as received without purification or 
drying. Thin-layer chromatography (TLC) was performed on pre-coated 
aluminium sheets of Merck silica gel 60 F254 (0.20 mm) and visualised by 
UV radiation (254 nm). Automated column chromatography was 
performed on a Biotage® Isolera Four using Biotage® cartridges SNAP 
Ultra 10 g. 1H NMR, 13C NMR and 19F NMR spectra were measured on 
Bruker DPX 400 or 500 apparatus and were referenced to the residual 
proton solvent peak (1H: CDCl3, δ 7.26 ppm; DMSO-d6, δ 2.50 ppm) and 
solvent 13C signal (CDCl3, δ 77.2 ppm, DMSO-d6, δ 39.5). Chemical shifts δ 
were reported in ppm, multiplicity of the signals was declared as followed: 
s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, sex = sextet, 
hep = septet, dd = doublet of doublets, m = multiplet, b = broad; and 
coupling constants (J) in Hertz. IR spectra were recorded on a Shimadzu 
FTIR Affinity-1S apparatus. Wavenumbers are quoted in cm–1. All 
compounds were measured neat directly on the crystal of the IR machine. 
Mass spectrometric measurements were performed by R. Jenkins, R. Hick, 
T. Williams and S. Waller at Cardiff University on a Water LCR Premier 
XEtof. Ions were generated by Electron Ionisation (EI) and Electron Spray 
(ES). The molecular ion peaks values quoted for either molecular ion [M]+, 
molecular ion plus hydrogen [M+H]+ or molecular ion plus sodium 
[M+Na]+. Melting points were measured using a Gallenkamp variable 
heater with samples in open capillary tubes. The electrochemical 
reactions were carried out in a galvanostatic mode using a Vapourtec Ion 
Electrochemical flow reactor5 
. The cyclic voltammograms (SI) were performed using an Orygalys 
OGF500 Potentiostat / Galvanostat with OGFPWR power supply. 
General procedure for electrochemical oxyselenenylations of 
alkenes (GP1): 
The electrolysis was performed in an undivided cell using a Vapourtec Ion 
Electrochemical Flow Reactor (reactor volume = 0.6 mL, spacer 0.5 mm) 
using a Graphite (Gr) electrode as the anode and a platinum (Pt) electrode 
as the cathode (active surface area: 2 x 12 cm2). A solution of alkene (0.15 
M in CH3CN) placed in vial A and mixture of diphenyl diselenide (0.05 M), 
alcohol (30 equiv) and TBAI (0.0075 M) in CH3CN was placed in vial B. 
Each solution was injected into an 8 mL sample loop. After that, the 
reactor temperature was set at 25 ºC with the flow rate 0.6 mL/min and 
the current was set at 192 mA to turn on automatically. Then, both 
solutions were pumped into a PTFE coil (1 mm internal diameter) and 
mixed via a T-piece connected to a 30 cm PTFE coil before the inlet of the 
electrochemical rector. After reaching a steady state, the solution (12 mL) 
was collected automatically into a collection glass vial. The solvent was 
removed under vacuum. The crude product was purified by column 
chromatography (EtOAc/hexane). 
General procedure for electrochemical selenocyclisations (GP2): 
The electrolysis was performed in an undivided cell using a Vapourtec Ion 
Electrochemical Flow Reactor (reactor volume = 0.6 mL, spacer 0.5 mm) 
using a Graphite (Gr) electrode as the anode and a platinum (Pt) electrode 
as the cathode (immersed surface area: A = 12 cm2). A solution of alkene 
(0.15 M in CH3CN) place in vial A and mixture of diphenyl diselenide (0.05 
M) and TBAI (0.0075 M) in CH3CN was placed in vial B. Each solution was 
injected to 8 ml sample loop. After that, the reactor temperature was set 


























on automatically. Then, both solutions were pumped into a PTFE coil (1 
mm internal diameter) and mix via a T-piece connected to 30 cm PTFE coil 
before the inlet of the electrochemical rector. After reaching a steady state, 
the solution (12 mL) was collected automatically into a collection glass 
vial. The solvent was removed under vacuum. The crude product was 
purified by column chromatography (EtOAc/hexane). 
(2-Methoxy-2-phenylethyl)(phenyl)selane (4) 
Compound 4 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 165 mg (95% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (500 MHz, CDCl3): δ = 7.50 – 7.45 (m, 2H), 7.38 – 7.29 (m, 5H), 
7.26 – 7.22 (m, 3H), 4.35 (dd, J = 8.4, 5.0 Hz, 1H), 3.33 (dd, J = 12.3, 8.4 Hz, 
1H), 3.25 (s, 3H), 3.11 (dd, J = 12.3, 5.0 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 141.0, 132.7, 130.8, 129.2, 128.7, 128.2, 
126.9, 126.8, 83.3, 57.2, 35.5 ppm 
(2-Methoxy-2-(p-tolyl)ethyl)(phenyl)selane (5) 
Compound 5 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 167 mg (91% yield). The spectral data are in 
agreement with literature.15 
1H NMR (400 MHz, CDCl3): δ = 7.49 – 7.44 (m, 2H), 7.26 – 7.14 (m, 7H), 
4.33 (dd, J = 8.4, 5.1 Hz, 1H), 3.33 (dd, J = 12.2, 8.4 Hz, 1H), 3.24 (s, 3H), 
3.10 (dd, J = 12.2, 5.1 Hz, 1H), 2.36 (s, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 137.7, 132.6, 130.9, 129.4, 129.1, 126.9, 
126.8, 83.1, 57.0, 35.5, 21.3 ppm 
(2-(4-(tert-Butyl)phenyl)-2-methoxyethyl)(phenyl)selane (6) 
Compound 6 was synthesised following GP1 as a yellow oil. It was purified 
by column chromatography on silica gel using hexane/ethyl acetate (20:1) 
to obtain 184 mg (88% yield). The spectral data are in agreement with 
literature.16 
1H NMR (500 MHz, CDCl3): δ = 7.51 – 7.43 (m, 2H), 7.40 – 7.38 (m, 2H), 
7.26 – 7.18 (m, 5H), 4.35 (dd, J = 8.5, 4.9 Hz, 1H), 3.33 (dd, J = 12.3, 8.5 Hz, 
1H), 3.25 (s, 3H), 3.11 (dd, J = 12.3, 4.9 Hz, 1H), 1.32 (s, 9H) ppm 
13C NMR (126 MHz, CDCl3): δ = 151.2, 138.0, 132.7, 130.9, 129.1, 126.9, 
126.5, 125.5, 83.3, 57.2, 35.5, 34.7, 31.6 ppm 
(2-Methoxy-2-(4-methoxyphenyl)ethyl)(phenyl)selane (7) 
Compound 7 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 122 mg (63% yield). The spectral data are in 
agreement with literature.15 
1H NMR (500 MHz, CDCl3): δ = 7.49 – 7.43 (m, 2H), 7.26 – 7.20 (m, 5H), 
6.89 – 6.82 (m, 2H), 4.31 (dd, J = 8.2, 5.3 Hz, 1H), 3.81 (s, 3H), 3.33 (dd, J = 
12.2, 8.3 Hz, 1H), 3.22 (s, 3H), 3.09 (dd, J = 12.2, 5.3 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 159.6, 133.0, 132.6, 130.9, 129.1, 128.0, 
126.9, 114.0, 82.8, 56.9, 55.4, 35.5 ppm 
(2-(4-Fluorophenyl)-2-methoxyethyl)(phenyl)selane (8) 
Compound 8 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 156 mg (84% yield). The spectral data are in 
agreement with literature.16 
1H NMR (500 MHz, CDCl3): δ = 7.50 – 7.42 (m, 2H), 7.29 – 7.20 (m, 5H), 
7.07 – 6.97 (m, 2H), 4.33 (dd, J = 8.0, 5.5 Hz, 1H), 3.30 (dd, J = 12.3, 8.0 Hz, 
1H), 3.23 (s, 3H), 3.07 (dd, J = 12.3, 5.5 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 162.6 (d, J = 243.7 Hz), 136.7 (d, J = 3.7 Hz), 
132.8, 129.2, 128.4 (d, J = 8.7 Hz), 127.0, 115.5 (d, J = 22.5 Hz), 82.7, 56.1, 
35.4 ppm 
(2-(4-Chlorophenyl)-2-methoxyethyl)(phenyl)selane (9) 
Compound 9 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 144 mg (74% yield). The spectral data are in 
agreement with literature.15 
1H NMR (400 MHz, CDCl3): δ = 7.49 – 7.44 (m, 2H), 7.32 – 7.28 (m, 2H), 
7.26 – 7.16 (m, 5H), 4.31 (dd, J = 7.9, 5.5 Hz, 1H), 3.29 (dd, J = 12.3, 8.0 Hz, 
1H), 3.23 (s, 3H), 3.06 (dd, J = 12.3, 5.5 Hz, 1H) ppm 
13C NMR (101 MHz, CDCl3): δ = 139.5, 133.9, 132.8, 130.5, 129.2, 128.9, 
128.2, 127.1, 82.7, 57.2, 35.2 ppm 
(2-(4-Bromophenyl)-2-methoxyethyl)(phenyl)selane (10) 
Compound 10 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (20:1) to obtain 194 mg (87% yield). The spectral data are in 
agreement with literature.16 
1H NMR (500 MHz, CDCl3): δ = 7.49 – 7.43 (m, 4H), 7.26 – 7.20 (m, 3H), 
7.18 – 7.14 (m, 2H), 4.30 (dd, J = 7.9, 5.5 Hz, 1H), 3.28 (dd, J = 12.4, 7.9 Hz, 
1H), 3.23 (s, 3H), 3.06 (dd, J = 12.4, 5.5 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 140.0, 132.9, 131.8, 130.5, 129.2, 128.9, 
127.1, 122.1, 82.7, 57.2, 35.2 ppm 
(2-([1,1'-Biphenyl]-4-yl)-2-methoxyethyl)(phenyl)selane (11) 
Compound 11 was synthesised following GP1 as a pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 184 mg (83% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.60 – 7.57 (m, 4H), 7.50 –7.44 (m, 4H), 7.39 
– 7.34 (m, 3H), 7.26 – 7.22 (m, 3H), 4.41 (dd, J = 8.3, 5.2 Hz, 1H), 3.37 (dd, 
J = 12.3, 8.3 Hz, 1H), 3.30 (s, 3H), 3.15 (dd, J = 12.3, 5.2 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 141.2, 140.9, 140.0, 132.8, 130.8, 129.1, 
128.9, 127.4, 127.4, 127.2, 127.2, 126.9, 83.1, 57.2, 35.5 ppm 
IR (neat): 3055, 2819, 1485, 1477, 1085, 732, 692 cm–1 
HRMS (ESI)+ calcd. for C20H17Se[M–OMe]+: 333.0522, found: 333.0525 
(2-Methoxy-2-(m-tolyl)ethyl)(phenyl)selane (12) 
Compound 12 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 170 mg (93% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.50 – 7.44 (m, 2H), 7.26 – 7.20 (m, 4H), 
7.12 – 7.09 (m, 3H), 4.32 (dd, J = 8.5, 5.0 Hz, 1H), 3.32 (dd, J = 12.2, 8.5 Hz, 
1H), 3.25 (s, 3H), 3.10 (dd, J = 12.2, 5.0 Hz, 1H), 2.35 (s, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 141.0, 138.4, 132.7, 130.9, 129.1, 129.0, 
128.6, 127.4, 126.9, 123.9, 83.4, 57.2, 35.5, 21.6 ppm 
IR (neat): 2981, 2820, 1477, 1437, 1084, 731 cm–1 
HRMS (ESI)+ calcd. for C15H15Se[M–OMe]+: 271.0366, found: 271.0374 
(2-(3-Fluorophenyl)-2-methoxyethyl)(phenyl)selane (13) 
Compound 13 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 114 mg (61% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.50 – 7.44 (m, 2H), 7.32 – 7.25 (m, 1H), 
7.24 – 7.21 (m, 3H), 7.09 – 6.96 (m, 3H), 4.33 (dd, J = 8.1, 5.2 Hz, 1H), 3.29 
(dd, J = 12.4, 8.2 Hz, 1H), 3.26 (s, 3H), 3.08 (dd, J = 12.4, 5.2 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 163.2 (d, J = 245.0 Hz), 143.9 (d, J = 6.2 Hz), 
132.9, 130.5, 130.2 (d, J = 7.5 Hz), 129.2, 127.1, 122.5 (d, J = 2.5 Hz), 115.1 
(d, J = 21.2 Hz), 113.7 (d, J = 25.0 Hz), 113.52, 82.8 (d, J = 2.5 Hz), 57.3, 35.2 
ppm 
19F NMR (471 MHz, CDCl3): δ = –112.69 (s) ppm 
IR (neat): 2932, 2822, 1477, 1436, 1089, 1072, 733 cm–1 
(2-(3-Chlorophenyl)-2-methoxyethyl)(phenyl)selane (14) 
Compound 14 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 138 mg (70% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.49 – 7.43 (m, 2H), 7.29 – 7.27 (m, 1H), 
7.27 – 7.21 (m, 5H), 7.19 – 7.14 (m, 1H), 4.30 (dd, J = 8.1, 5.3 Hz, 1H), 3.27 
(dd, J = 12.4, 8.1 Hz, 1H), 3.24 (s, 3H), 3.06 (dd, J = 12.4, 5.3 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 143.2, 134.7, 133.0, 130.5, 130.0, 129.2, 
128.4, 127.1, 127.0, 125.0, 82.8, 57.4, 35.2 ppm 
IR (neat): 2986, 2821, 1475, 1437, 1099, 1074, 733 cm–1 
HRMS (ESI)+ calcd. for C14H12ClSe[M–OMe]+ 290.9820, found: 290.9810 
(2-(3-Bromophenyl)-2-methoxyethyl)(phenyl)selane (15) 
Compound 15 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 187 mg (84% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.48 – 7.40 (m, 4H), 7.26 – 7.18 (m, 5H), 
4.30 (dd, J = 8.1, 5.3 Hz, 1H), 3.28 (dd, J = 12.4, 8.1 Hz, 1H), 3.25 (s, 3H), 
3.06 (dd, J = 12.4, 5.3 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 143.5, 132.9, 131.3, 130.4, 130.3, 129.9, 
129.2, 127.2, 125.5, 122.9, 82.8, 57.4, 35.2 ppm 
IR (neat): 2984, 2819, 1476, 1436, 1082, 1070, 732, 688 cm–1 
 (2-Methoxy-2-(o-tolyl)ethyl)(phenyl)selane (16) 
Compound 16 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 154 mg (84% yield). 
1H NMR (400 MHz, CDCl3): δ = 7.53 – 7.50 (m, 2H), 7.40 – 7.38 (m, 1H), 
7.25 – 7.11 (m, 6H), 4.60 (dd, J = 9.0, 4.2 Hz, 1H), 3.31 – 3.17 (m, 4H), 3.07 
(dd, J = 12.5, 4.2 Hz, 1H), 2.22 (s, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 139.1, 135.7, 133.2, 130.7, 130.6, 129.1, 
127.8, 127.1, 126.5, 126.0, 79.7, 57.1, 34.7, 19.1 ppm 
IR (neat): 2980, 2820, 1477, 1437, 1022, 729 cm–1 
HRMS (ESI)+ calcd. for C15H15Se[M–OMe]+: 271.0366, found: 271.035 
(2-(2-Fluorophenyl)-2-methoxyethyl)(phenyl)selane (17) 
Compound 17 was synthesised following GP1 as a pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 120 mg (64% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.51 – 7.48 (m, 2H), 7.44 – 7.40 (m, 1H), 
7.29 – 7.22 (m, 4H), 7.18 – 7.14 (m, 1H), 7.04 – 7.00 (m, 1H), 4.75 (dd, J = 
8.2, 4.9 Hz, 1H), 3.32 – 3.25 (m, 4H), 3.20 (dd, J = 12.7, 4.6 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 160.5 (d, J = 245.0 Hz), 132.8, 130.6, 129.5 
(d, J = 8.7 Hz), 129.1, 128.0 (d, J = 13.7 Hz), 127.7 (d, J = 3.7 Hz), 127.0, 
124.5 (d, J = 3.7 Hz), 115.5 (d, J = 22.5 Hz), 76.6 (d, J = 1.3 Hz), 57.5, 34.1 
ppm 
19F NMR (471 MHz, CDCl3) δ = –119.2 ppm 
IR (neat): 3086, 2824, 1477, 1436, 1105, 1088, 734 cm–1 
 (2-(2-Chlorophenyl)-2-methoxyethyl)(phenyl)selane (18) 
Compound 18 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 134 mg (69% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.55 – 7.49 (m, 3H), 7.34 – 7.28 (m, 2H), 
7.26 – 7.19 (m, 4H), 4.85 (dd, J = 8.7, 3.9 Hz, 1H), 3.29 (s, 3H), 3.23 (dd, J = 
12.5, 3.9 Hz, 1H), 3.16 (dd, J = 12.5, 8.7 Hz, 1H) ppm 
13C NMR (101 MHz, CDCl3): δ = 138.6, 133.2, 133.1, 130.6, 129.7, 129.1, 
127.4, 127.4, 127.0, 79.3, 57.6, 34.1 ppm 
IR (neat): 2985, 2823, 1475, 1436, 1072.1034, 733 cm–1 
HRMS (ESI)+ calcd. for C14H12ClSe[M–OMe]+: 290.9820, found: 290.9812 
(2-(2-Bromophenyl)-2-methoxyethyl)(phenyl)selane (19) 
Compound 19 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 178 mg (80% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.56 – 7.53 (m, 2H), 7.52 – 7.47 (m, 2H), 
7.36 – 7.32 (m, 1H), 7.25 – 7.20(m, 3H), 7.16 – 7.13 (m, 1H), 4.79 (dd, J = 
8.9, 3.7 Hz, 1H), 3.29 (s, 3H), 3.22 (dd, J = 12.6, 3.7 Hz, 1H), 3.13 (dd, J = 
12.6, 8.9 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 143.5, 133.0, 131.3, 130.4, 130.3, 129.9, 
129.2, 127.2, 125.5, 122.9, 82.8, 57.4, 35.2 ppm 
IR (neat): 3055, 2824, 1475, 1435, 1072.1022, 732, 690 cm–1 
HRMS (ESI)+ calcd. for C14H12BrSe[M–OMe] + 334.9315, found: 334.9301 
(2-Methoxy-2-phenylpropyl)(phenyl)selane (20) 
Compound 20 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 138 mg (75% yield). The spectral data are in 
agreement with literature.17 
1H NMR (500 MHz, CDCl3): δ = 7.43 – 7.39 (m, 4H), 7.36 – 7.32 (m, 2H), 
7.29 – 7.25 (m, 1H), 7.20 – 7.16 (m, 3H), 3.43 (d, J = 11.3 Hz, 1H), 3.28 (d, J 
= 11.8 Hz, 1H), 3.13 (s, 3H), 1.72 (s, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 143.8, 132.8, 131.5, 129.0, 128.4, 127.5, 
126.8, 126.4, 79.1, 51.2, 42.6, 23.3 ppm 
(2-Methoxy-3-methyl-2-phenylbutyl)(phenyl)selane (21) 
Compound 21 was synthesised following GP1 as a colourless solid. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 32 mg (16% yield). 
m.p. = 87 – 88 ºC 
1H NMR (500 MHz, CDCl3): δ = 7.60 – 7.55 (m, 2H), 7.36 – 7.24 (m, 8H), 
3.79 (d, J = 12.0 Hz, 1H), 3.62 (d, J = 12.0 Hz, 1H), 3.26 (s, 3H), 2.41 (dt, J = 
13.6, 6.8 Hz, 1H), 0.79 (d, J = 6.7 Hz, 3H), 0.75 (d, J = 6.9 Hz, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 139.3, 133.3, 131.0, 129.2, 128.0, 127.6, 
127.1, 127.1, 83.7, 50.9, 35.4, 34.8, 18.2, 16.9 ppm 
IR (neat): 2966, 2818, 1471, 1170, 1070, 761, 744, 705, 690 cm–1 
(2-Methoxy-2,2-diphenylethyl)(phenyl)selane (22) 
Compound 22 was synthesised following GP1 as a colourless solid. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 56 mg (25% yield). The spectral data are in 
agreement with literature.18 
m.p. = 76 – 78 ºC 
1H NMR (500 MHz, CDCl3): δ = 7.44 – 7.34 (m, 6H), 7.33 – 7.28 (m, 4H), 
7.26 – 7.17 (m, 5H), 3.96 (s, 2H), 3.16 (s, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 144.3, 133.3, 130.9, 129.0, 128.1, 127.3, 
127.1, 127.0, 82.2, 50.9, 37.9 ppm 
(1-Methoxy-1-phenylpropan-2-yl)(phenyl)selane (23) 
Compound 23 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 153 mg (84% yield). The spectral data are in 
agreement with literature.19 
1H NMR (400 MHz, CDCl3): δ = 7.56 – 7.53 (m, 2H), 7.38 – 7.22 (m, 8H), 
4.41 (d, J = 4.5 Hz, 1H), 3.48 (qd, J = 7.0, 4.5 Hz, 1H), 3.30 (s, 3H), 1.35 (d, J 
= 7.1 Hz, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 139.8, 134.7, 130.1, 129.1, 128.4, 127.9, 
127.5, 127.2, 86.5, 57.7, 45.9, 16.5 ppm 
(2-Methoxy-2-(naphthalen-2-yl)ethyl)(phenyl)selane (26) 
Compound 26 was synthesised following GP1 as a orange oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 177 mg (86% yield). 
1H NMR (400 MHz, CDCl3): δ = 7.87 – 7.81 (m, 3H), 7.75 (s, 1H), 7.52 – 7.42 
(m, 5H), 7.25 – 7.14 (m, 3H), 4.52 (dd, J = 8.3, 5.2 Hz, 1H), 3.40 (dd, J = 12.3, 
4.0 Hz, 1H), 3.29 (s, 3H), 3.19 (dd, J = 12.3, 5.2 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 138.5, 134.4, 133.5, 133.4, 132.9, 130.8, 
129.2, 128.8, 128.2, 127.9, 127.1, 126.5, 126.4, 126.3, 124.3, 83.6, 77.3, 
57.3, 35.4 ppm 
IR (neat): 3050, 2931, 1477, 1437, 1101, 1022, 735 cm–1 
HRMS (ESI)+ calcd. for C18H15Se[M–OMe]+: 307.0366, found: 307.0359 
(1-Methoxy-2,3-dihydro-1H-inden-2-yl)(phenyl)selane (27) 
Compound 27 was synthesised following GP1 as a orange oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 168 mg (92% yield). The spectral data are in 
agreement with literature.16 
1H NMR (400 MHz, CDCl3): δ = 7.62 – 7.57 (m, 2H), 7.39 (d, J = 7.1 Hz, 1H), 
7.32 – 7.19 (m, 6H), 4.76 (d, J = 2.8 Hz, 1H), 4.08 – 3.97 (m, 1H), 3.60 (dd, J 
= 17.0, 7.4 Hz, 1H), 3.36 (s, 3H), 2.94 (dd, J = 17.0, 3.7 Hz, 1H) ppm 
13C NMR (101 MHz, CDCl3): δ = 142.3, 140.9, 134.4, 129.6, 129.3, 129.1, 
127.8, 127.0, 125.7, 125.3, 90.3, 57.0, 44.8, 38.4 ppm 
(2-Cyclopentyl-2-methoxyethyl)(phenyl)selane (28a) and (1-
Cyclopentyl-2-methoxyethyl)(phenyl)selane (28b) 
Compounds 28a and 28b were synthesised following GP1 as a colourless 
oil. It was purified by column chromatography on silica gel using 
hexane/ethyl acetate (30:1) to obtain 127 mg (75% yield). The spectral 
data are in agreement with literature.16 
1H NMR (500 MHz, CDCl3): δ = 7.60 – 7.56 (a; m, 3H), 7.54 – 7.51 (b; m, 
2H), 7.28 – 7.20 (a + b; m, 8H), 3.59– 3.56 (a + b; m, 3H), 3.38 (b; s, 3H), 
3.32 (a; s, 3H), 3.32 – 3.22 (a + b; m, 3H), 3.16 (a; dd, J = 12.3, 4.8 Hz, 1H), 
3.08 (a; dd, J = 12.3, 5.8 Hz, 1H), 2.31 – 2.09 (a + b; m, 2.6H), 1.94 – 1.15 (a 
+ b; m, 20H) ppm 
13C NMR (126 MHz, CDCl3): δ = 134.6, 132.7, 131.1, 130.10, 129.2, 129.1, 
127.4, 126.9, 84.4, 75.71, 58.9, 58.0, 51.85, 44.3, 42.1, 31.7, 31.5, 31.2, 
29.35, 28.7, 25.7, 25.6, 25.64, 25.38 ppm 
IR (neat): 2947, 2866, 1577, 1475, 1436, 1095, 906, 729, 690 cm–1 
HRMS (ESI)+ calcd. for C13H17Se[M–OMe]+: 249.0522, found: 249.0524. 
(2-cyclohexyl-2-methoxyethyl)(phenyl)selane (29a) and (1-
cyclohexyl-2-methoxyethyl)(phenyl)selane (29b) 
Compound 29 was synthesised following the GP1 as pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 43% isolated yield (76 mg). 
1H NMR (500 MHz, CDCl3): δ = 7.59 – 7.51 (a + b; m, 3.6H), 7.29 – 7.20 (a 
+ b; m, 6H), 3.68 (a; dd, J = 10.1, 8.5 Hz, 1H), 3.56 (a; dd, J = 10.1, 5.1 Hz, 
1H), 3.38 (b; s, 3H), 3.30 (a; s, 3H), 3.26 – 3.22 (a; m, 1H), 3.21 – 3.03 (a + 
b; m, 2.5H), 1.89 – 1.40 (a + b; m, 12H), 1.35 – 1.05 (a + b; m, 8H) ppm 
13C NMR (126 MHz, CDCl3); δ = 134.2, 132.7, 131.1, 130.5, 129.1, 129.1, 
127.2, 126.8, 85.2, 74.0, 58.7, 58.3, 53.1, 41.4, 39.3, 31.7, 30.1, 30.0, 29.0, 
28.3, 26.6, 26.5, 26.54, 26.4, 26.3 ppm 
IR (neat): 2974, 2920, 2850, 1577, 1475, 1436, 1097, 1083, 1022, 734, 690 
cm–1 
HRMS (ESI)+ calcd. for C14H19Se[M–OMe]+ 263.0679, found: 263.0685. 
(2-Methoxyoctyl)(phenyl)selane (30a) and (1-Methoxyoctan-2-
yl)(phenyl)selane (30b) 
Compounds 30a and 30b were synthesised following GP1 as a colourless 
oil. It was purified by column chromatography on silica gel using 
hexane/ethyl acetate (30:1) to obtain 75 mg (42% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.50 – 7.44 (a + b; m, 2H), 7.20 – 7.14 (a + 
b; m, 4H), 3.48 (b; dd, J = 9.9, 5.2 Hz, 1H) , 3.42 (b; dd, J = 9.9, 7.5 Hz, 1H), 
3.33 – 3.27 (a; m, 1H), 3.26 (a; s, 3H), 3.25 (b; s, 3H), 3.23 – 3.18 (b; s,1H), 
3.03 (a; dd, J = 12.2, 5.5 Hz, 1H), 2.94 (a; dd, J = 12.2, 6.1 Hz, 1H), 1.58 – 
1.13 (a + b; m, 12.5H), 0.80 (a + b; m, 3.75H) ppm 
13C NMR (126 MHz, CDCl3): δ = 134.9, 133.0, 132.8, 130.9, 129.2, 129.1, 
127.6, 126.9, 80.6, 76.0, 58.8, 57.1, 45.0, 32.3, 32.1, 31.9, 31.8, 29.4, 29.2, 
27.8, 25.4, 22.7, 14.2 ppm 
IR (neat): 2926, 2854, 1577, 1477, 1436, 1091, 1074, 734, 690 cm–1 
(2-Methoxycyclohexyl)(phenyl)selane (31) 
Compound 31 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 130 mg (80% yield). The spectral data are in 
agreement with literature.20 
1H NMR (500 MHz, CDCl3): δ = 7.56-7.56 (m, 2H), 7.28 – 7.23 (m, 3H), 3.38 
(s, 3H), 3.27 (m, 1H), 3.18 (m, 1H), 2.15 (m, 1H), 2.04 – 1.97 (m, 1H), 1.76 
– 1.45 (m, 3H), 1.38 – 1.19 (m, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 135.5, 129.1, 128.9, 127.5, 82.4, 56.5, 47.5, 
32.3, 30.4, 25.9, 23.6 ppm 
2-Methoxy-3-(phenylselanyl)tetrahydro-2H-pyran (32) 
Compound 32 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 23 mg (14% yield). The spectral data are in 
agreement with literature.21 
1H NMR (500 MHz, CDCl3): δ = 7.59 – 7.54 (m, 2H), 7.30 – 7.23 (m, 3H), 
4.51 (d, J = 4.9 Hz, 1H), 3.90 (ddd, J = 11.2, 7.4, 3.6 Hz, 1H), 3.58 – 3.49 (m, 
1H), 3.42 (s, 3H), 3.27 (dt, J = 7.4, 4.6 Hz, 1H), 2.20 (ddd, J = 16.9, 8.1, 3.9 
Hz, 1H), 1.86 – 1.68 (m, 2H), 1.57 – 1.48 (m, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 134.9, 129.1, 129.0, 127.7, 103.2, 62.9, 
55.7, 44.2, 27.5, 24.4 ppm 
1-Methyl-3-(phenylselanyl)-1H-indole (33) 
Compound 33 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (9:1) to obtain 125 mg (72% yield). The spectral data are in 
agreement with literature.22 
1H NMR (500 MHz, CDCl3): δ = 7.58 – 7.55 (m, 1H), 7.31 (dt, J = 8.2, 0.9 Hz, 
1H), 7.26 – 6.95 (m, 8H), 3.78 (s, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 137.6, 135.8, 134.4, 130.8, 129.0, 128.8, 
125.6, 122.6, 120.6, 120.6, 109.7, 96.1, 33.2 ppm 
Benzyl(2-methoxy-2-phenylethyl)selane (34) 
Compound 34 was synthesised following GP1 as a pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 76 mg (41% yield). The spectral data are in 
agreement with literature.16 
1H NMR (500 MHz, CDCl3): δ = 7.38 – 7.33 (m, 2H), 7.32 – 7.23 (m, 7H), 
7.23 – 7.17 (m, 1H), 4.20 (dd, J = 8.0, 5.4 Hz, 1H), 3.70 (d, J = 2.3 Hz, 2H), 
3.22 (s, 3H), 2.90 (dd, J = 12.7, 8.0 Hz, 1H), 2.67 (dd, J = 12.7, 5.4 Hz, 1H) 
ppm 
13C NMR (101 MHz, CDCl3): δ = 141.3, 139.5, 129.1, 128.6, 128.5, 128.1, 
126.8, 126.8, 84.3, 57.0, 31.0, 28.0 ppm 
(2-Ethoxy-2-phenylethyl)(phenyl)selane (35) 
Compound 35 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 157 mg (86% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (400 MHz, CDCl3): δ = 7.56 – 7.43 (m, 2H), 7.38 – 7.19 (m, 8H), 
4.47 (dd, J = 8.5, 5.1 Hz, 1H), 3.38 (m, 3H), 3.10 (dd, J = 12.2, 5.1 Hz, 1H), 
1.19 (t, J = 7.0 Hz, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 141.8, 132.7, 131.0, 129.1, 128.6, 128.1, 
126.9, 126.7, 81.5, 64.8, 35.7, 15.4 ppm 
Phenyl(2-phenyl-2-propoxyethyl)selane (36) 
Compound 36 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 152 mg (79% yield). 
1H NMR (400 MHz, CDCl3): δ = 7.51 – 7.30 (m, 2H), 7.28 – 7.06 (m, 8H), 
4.36 (dd, J = 8.6, 4.9 Hz, 1H), 3.19 (m, 3H), 2.99 (dd, J = 12.2, 4.9 Hz, 1H), 
1.58 – 1.39 (m, 2H), 0.81 (t, J = 7.4 Hz, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 141.9, 132.6, 131.2, 129.1, 128.6, 128.1, 
126.8, 126.7, 81.7, 71.2, 35.9, 23.1, 10.8 ppm 
IR (neat): 2958, 2874, 1477, 1091, 734, 700 cm–1 
(2-Butoxy-2-phenylethyl)(phenyl)selane (37) 
Compound 37 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 148 mg (74% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (400 MHz, CDCl3): δ = 7.53 – 7.41 (m, 2H), 7.38 – 7.16 (m, 8H), 
4.46 (dd, J = 8.7, 4.9 Hz, 1H), 3.40 – 3.23 (m, 3H), 3.09 (dd, J = 12.2, 4.9 Hz, 
1H), 1.54 (m, 2H), 1.43 – 1.31 (m, 2H), 0.89 (t, J = 7.3 Hz, 3H) ppm 
13C NMR (101 MHz, CDCl3): δ = 141.9, 132.6, 131.2, 129.1, 128.6, 128.1, 
126.8, 126.7, 81.7, 69.3, 35.9, 32.0, 19.5, 14.0 ppm 
(2-(Benzyloxy)-2-phenylethyl)(phenyl)selane (38) 
Compound 38 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 119 mg (54% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (400 MHz, CDCl3): δ = 7.48 – 7.42 (m, 2H), 7.40 – 7.27 (m, 10H), 
7.25 – 7.17 (m, 3H), 4.58 (dd, J = 8.4, 5.0 Hz, 1H), 4.50 (d, J = 11.8 Hz, 1H), 
4.32 (d, J = 11.8 Hz, 1H), 3.45-3.83 (m, 1H), 3.12-3.18 (m, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 141.2, 138.2, 132.6, 130.9, 129.1, 128.8, 
128.5, 128.3, 128.0, 127.7, 126.9, 126.9, 80.9, 71.0, 35.7 ppm 
 (2-(But-3-yn-1-yloxy)-2-phenylethyl)(phenyl)selane (39) 
Compound 39 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 112 mg (57% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.50 – 7.47 (m, 2H), 7.37 – 7.28 (m, 5H), 
7.25 – 7.20 (m, 3H), 4.51 (dd, J = 8.5, 5.0 Hz, 1H), 3.52-3.42(m, 2H), 3.35 
(dd, J = 12.4, 8.5 Hz, 1H), 3.09 (dd, J = 12.4, 5.0 Hz, 1H), 2.50-2.40 (m, 2H), 
1.95 (t, J = 2.7 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 141.2, 132.7, 130.9, 129.1, 128.7, 128.3, 
126.9, 126.8, 82.1, 81.3, 69.5, 67.4, 35.5, 20.0 ppm 
IR (neat): 3057, 2868, 1477, 1437, 1095, 733, 700 cm–1 
HRMS (ESI)+ calcd. for C18H18OSeNa [M+Na]+: 349.0447, found: 349.0448 
(2-(Cyclopropylmethoxy)-2-phenylethyl)(phenyl)selane (40) 
Compound 40 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 150 mg (75% yield). The spectral data are in 
agreement with literature.17 
1H NMR (500 MHz, CDCl3): δ = 7.44 – 7.41 (m, 2H), 7.29 – 7.13 (m, 8H), 
4.44 (dd, J = 8.4, 5.2 Hz, 1H), 3.31 (dd, J = 12.2, 8.5 Hz, 1H), 3.15 – 3.07 (m, 
2H), 3.04 (dd, J = 12.2, 5.1 Hz, 1H), 1.03 – 0.93 (m, 1H), 0.47 – 0.38 (m, 2H), 
0.12 – 0.01 (m, 2H) ppm 
13C NMR (126 MHz, CDCl3): δ = 141.7, 132.6, 131.0, 129.1, 128.6, 128.1, 
126.8, 126.7, 81.22, 74.0, 35.8, 10.8, 3.4, 3.1 ppm 
IR (neat): 3003, 2858, 1477, 1437, 1089, 1022, 733, 700 cm–1 
HRMS (ESI)+ calcd. for C18H20OSeNa [M+Na]+: 351.0604, found: 351.0615 
 (2-Isopropoxy-2-phenylethyl)(phenyl)selane (41) 
Compound 41 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 134 mg (70% yield). The spectral data are in 
agreement with literature.17 
1H NMR (400 MHz, CDCl3): δ = 7.54 – 7.40 (m, 2H), 7.35 – 7.11 (m, 8H), 
4.59 (dd, J = 9.9, 3.6 Hz, 1H), 3.60 – 3.44 (m, 1H), 3.31 (dd, J = 12.1, 8.8 Hz, 
1H), 3.08 (dd, J = 12.1, 4.8 Hz, 1H), 1.17 (d, J = 6.0 Hz, 3H), 1.08 (d, J = 6.2 
Hz, 3H) ppm 
13C NMR (101 MHz, CDCl3) δ 142.6, 132.5, 131.2, 129.1, 128.6, 128.0, 
126.7, 78.9, 69.9, 36.2, 23.4, 21.5 ppm 
(2-Isobutoxy-2-phenylethyl)(phenyl)selane (42) 
Compound 42 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 150 mg (75% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (400 MHz, CDCl3): δ = 7.56 – 7.43 (m, 2H), 7.38 – 7.18 (m, 8H), 
4.46 (dd, J = 8.8, 4.8 Hz, 1H), 3.36 (dd, J = 12.1, 8.8 Hz, 1H), 3.16 – 3.01 (m, 
3H), 1.86 (m, 1H), 0.98 – 0.81 (m, 6H) ppm 
13C NMR (101 MHz, CDCl3): δ = 142.6, 132.4, 131.2, 129.1, 128.5, 127.9, 
126.7, 78.9, 69.9, 36.2, 23.4, 21.5 ppm 
(2-(Cyclopentyloxy)-2-phenylethyl)(phenyl)selane (43) 
Compound 43 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 148 mg (71% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.45 – 7.37 (m, 2H), 7.29 – 7.10 (m, 8H), 
4.47 (dd, J = 9.2, 4.4 Hz, 1H), 3.92 – 3.52 (m, 1H), 3.22 (dd, J = 12.2, 9.2 Hz, 
1H), 2.99 (dd, J = 12.2, 4.5 Hz, 1H), 1.74 – 1.34 (m, 8H) ppm 
13C NMR (126 MHz, CDCl3): δ = 142.5, 132.4, 131.4, 129.1, 128.6, 127.9, 
126.8, 126.7, 79.6, 79.4, 36.2, 33.2, 31.7, 23.5 ppm 
IR (neat): 3057, 2868, 1476, 1437, 1072, 1022, 732, 700 cm–1 
(2-(Cyclohexyloxy)-2-phenylethyl)(phenyl)selane (44) 
Compound 44 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 135 mg (62% yield). 
1H NMR (500 MHz, CDCl3): δ = 7.40 (m, 2H), 7.29 – 7.09 (m, 8H), 4.57 (dd, 
J = 9.0, 4.6 Hz, 1H), 3.24 (dd, J = 12.1, 9.0 Hz, 1H), 3.16 – 3.07 (m, 1H), 2.99 
(dd, J = 12.1, 4.6 Hz, 1H), 1.68 (m, 4H), 1.42 – 0.92 (m, 6H) ppm 
13C NMR (126 MHz, CDCl3): δ = 142.8, 132.3, 131.4, 129.1, 128.5, 127.9, 
126.7, 126.6, 78.5, 75.7, 36.4, 33.5, 31.4, 25.9, 24.2, 24.0 ppm 
IR (neat): 2927, 2854, 1477, 1436, 1070, 733, 700 cm–1 
(2-(tert-Butoxy)-2-phenylethyl)(phenyl)selane (45) 
Compound 45 was synthesised following GP1 as a yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (30:1) to obtain 93 mg (47% yield). 
1H NMR (400 MHz, CDCl3): δ = 7.41 – 7.31 (m, 2H), 7.27 – 7.06 (m, 8H), 
4.60 (dd, J = 8.6, 4.8 Hz, 1H), 3.14 (dd, J = 12.1, 8.6 Hz, 1H), 2.95 (dd, J = 
12.1, 4.8 Hz, 1H), 1.02 (s, 9H) ppm 
13C NMR (101 MHz, CDCl3): δ = 145.3, 132.2, 131.5, 129.1, 128.4, 127.4, 
126.6, 126.3, 75.0, 74.2, 37.4, 28.9 ppm 
IR (neat): 2972, 2931, 1477, 1436, 1072, 1190, 731, 700 cm–1 
1-Phenyl-2-(phenylselanyl)ethan-1-ol (46) 
Compound 46 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (9:1) to obtain 134 mg (81% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (500 MHz, CDCl3): δ = 7.60 – 7.51 (m, 2H), 7.38 – 7.32 (m, 4H), 
7.32 – 7.26 (m, 4H), 4.76 (dd, J = 9.4, 3.5 Hz, 1H), 3.31 (dd, J = 12.8, 3.7 Hz, 
1H), 3.15 (dd, J = 12.8, 9.4 Hz, 1H), 2.79 (s, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 142.6, 133.3, 129.4, 129.3, 128.7, 128.1, 
127.6, 125.9, 72.4, 38.6 ppm 
1-Phenyl-2-(phenylselanyl)ethyl formate (47) 
Compound 47 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 76 mg (41% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (500 MHz, CDCl3): δ = 8.00 (s, 1H), 7.44 – 7.40 (m, 2H), 7.30 – 7.13 
(m, 8H), 5.94 (dd, J = 8.9, 5.8 Hz, 1H), 3.32 (dd, J = 12.9, 8.0 Hz, 1H), 3.18 
(dd, J = 13.2, 6.1 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 160.0, 138.8, 135.5, 133.4, 129.3, 128.8, 
128.7, 127.5, 126.8, 75.1, 33.2 ppm 
1-Phenyl-2-(phenylselanyl)ethyl acetate (48) 
Compound 48 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 92 mg (46% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (500 MHz, CDCl3): δ = 7.46 – 7.40 (m, 2H), 7.28 – 7.16 (m, 8H), 
5.87 (dd, J = 8.0, 5.7 Hz, 1H), 3.31 (dd, J = 12.8, 8.0 Hz, 1H), 3.16 (dd, J = 
12.8, 5.7 Hz, 1H), 1.95 (s, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 170.1, 139.5, 133.2, 129.9, 129.2, 128.6, 
128.5, 127.3, 126.7, 75.3, 33.5, 21.2 ppm 
1-(1-Phenyl-2-(phenylselanyl)ethyl)-1H-benzo[d][1,2,3]triazole 
(49) 
Compound 49 was synthesised following GP1 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (9:1) to obtain 147 mg (65% yield). The spectral data are in 
agreement with literature.10a 
1H NMR (500 MHz, CDCl3): δ = 8.10 – 7.94 (m, 1H), 7.46 – 7.39 (m, 2H), 
7.38 – 7.19 (m, 11H), 5.85 (dd, J = 9.4, 5.8 Hz, 1H), 4.25 (dd, J = 13.1, 9.4 
Hz, 1H), 3.82 (dd, J = 13.1, 5.8 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 146.1, 138.4, 133.7, 133.1, 129.3, 129.0, 
129.0, 128.8, 127.8, 127.3, 126.9, 124.0, 120.1, 109.6, 63.6, 32.6 ppm 
2-((Phenylselanyl)methyl)tetrahydrofuran (50) 
Compound 50 was synthesised following GP2 as a pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 105 mg (73% yield). The spectral data are in 
agreement with literature.25 
1H NMR (500 MHz, CDCl3): δ = 7.59 – 7.50 (m, 2H), 7.30 – 7.22 (m, 3H), 
4.30 – 4.03 (m, 1H), 4.01 – 3.88 (m, 1H), 3.84 – 3.66 (m, 1H), 3.15 (dd, J = 
12.2, 5.8 Hz, 1H), 3.01 (dd, J = 12.2, 6.9 Hz, 1H), 2.14 – 2.05 (m, 1H), 2.03 – 
1.80 (m, 2H), 1.65 (m, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 137.4, 132.7, 129.2, 127.0, 78.4, 78.4, 33.2, 
31.7, 26.1 ppm 
2-((Phenylselanyl)methyl)tetrahydro-2H-pyran (51) 
Compound 51 was synthesised following GP2 as a pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 103 mg (67% yield). The spectral data are in 
agreement with literature.25 
1H NMR (500 MHz, CDCl3): δ = 7.55 – 7.46 (m, 2H), 7.29 – 7.18 (m, 3H), 
4.04 – 3.95 (m, 1H), 3.92 – 3.26 (m, 2H), 3.07 (dd, J = 12.2, 6.9 Hz, 1H), 2.93 
(dd, J = 12.2, 5.7 Hz, 1H), 1.99 – 1.68 (m, 2H), 1.61 – 1.43 (m, 3H), 1.37 – 
1.26 (m, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 132.5, 130.9, 129.1, 126.8, 77.2, 68.9, 33.8, 
31.9, 25.9, 23.5 ppm 
2-((Phenylselanyl)methyl)tetrahydro-2H-pyran (52) 
Compound 52 was synthesised as a 1:1 mixture (cis : trans) following GP2 
as a colourless oil. It was purified by column chromatography on silica gel 
using hexane/ethyl acetate (9:1) to obtain 89 mg (58% yield). The 
spectral data are in agreement with literature.21 
1H NMR (500 MHz, CDCl3): δ = 7.61 – 7.55 (m, 4H), 7.31 – 7.23 (m, 6H), 
3.96 – 3.86 (m, 3H), 3.78 (dt, J = 9.4, 6.6 Hz, 1H), 3.46 – 3.29 (m, 3H), 2.99 
– 2.89 (m, 1H), 2.22 – 2.10 (m, 1H), 2.09 – 1.99 (m, 1H), 1.95 – 1.83 (m, 
2H), 1.75 – 1.53 (m, 4H), 1.44 (d, J = 7.0 Hz, 3H), 1.35 (d, J = 6.1 Hz, 3H) 
ppm 
13C NMR (126 MHz, CDCl3): δ = 135.6, 135.3, 134.9, 129.1, 129.0, 128.2, 
127.9, 127.6, 83.0, 78.4, 68.6, 68.2, 47.2, 44.4, 32.5, 30.4, 28.2, 26.3, 21.3, 
18.9 ppm 
5-((Phenylselanyl)methyl)dihydrofuran-2(3H)-one (53) 
Compound 53 was synthesised following GP2 as a pale yellow oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 101 mg (65% yield). The spectral data are in 
agreement with literature.20 
1H NMR (500 MHz, CDCl3): δ = 7.62 – 7.46 (m, 2H), 7.33 – 7.26 (m, 3H), 
4.69 – 4.61 (m, 1H), 3.29 (dd, J = 12.9, 4.8 Hz, 1H), 3.01 (dd, J = 12.9, 8.0 
Hz, 1H), 2.62 – 2.36 (m, 3H), 2.00 – 1.90 (m, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 176.7, 133.4, 129.5, 128.9, 127.8, 79.5, 
32.0, 28.9, 27.8 ppm 
5-Phenyl-4-(phenylselanyl)dihydrofuran-2(3H)-one (54) 
Compound 54 was synthesised following GP2 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
(1) (a) Alcácer, V.; Cruz-Machado, V. Eng. Sci. Technol. Int. J. 2019, 22, 
899. (b) Fitzpatrick, D. E.; Battilocchio, C.; Ley S. V. ACS Cent. Sci. 
2016, 2, 131. (c) Kreimeyer, A.; Eckes, P.; Fischer, C.; Lauke, H.; 
acetate (4:1) to obtain 58 mg (30% yield). The spectral data are in 
agreement with literature.23 
1H NMR (400 MHz, CDCl3): δ = 7.55 – 7.52 (m, 2H), 7.40 – 7.28 (m, 8H), 
5.38 (d, J = 6.9 Hz, 1H), 3.79– 3.71 (m, 1H), 3.04 (dd, J = 18.0, 8.3 Hz, 1H), 
2.67 (dd, J = 18.0, 8.4 Hz, 1H) ppm 
13C NMR (101 MHz, CDCl3): δ = 174.7, 137.4, 136.3, 129.7, 129.2, 129.1, 
128.9, 126.1, 125.9, 86.3, 42.38, 36.1 ppm 
6-(Phenylselanyl)hexahydro-2H-cyclopenta[b]furan-2-one (55) 
Compound 55 was synthesised following GP2 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 115 mg (68% yield). The spectral data are in 
agreement with literature.24 
1H NMR (500 MHz, CDCl3): δ = 7.64 – 7.42 (m, 2H), 7.34 – 7.25 (m, 3H), 
4.90 (d, J = 6.3 Hz, 1H), 3.97 – 3.78 (m, 1H), 3.15 – 3.04 (m, 1H), 2.87 – 2.73 
(m, 1H), 2.34 (dd, J = 18.4, 2.5 Hz, 1H), 2.28 – 2.18 (m, 2H), 1.91 – 1.71 (m, 
1H), 1.61 – 1.51 (m, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 177.0, 133.8, 129.5, 128.8, 127.9, 90.7, 
46.4, 37.2, 36.1, 32.6, 30.2 ppm 
3-((Phenylselanyl)methyl)isobenzofuran-1(3H)-one (56) 
Compound 56 was synthesised following GP2 as a colourless oil. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 87 mg (48% yield). The spectral data are in 
agreement with literature.25 
1H NMR (500 MHz, CDCl3): δ = 7.97 – 7.87 (m, 1H), 7.60 – 7.45 (m, 5H), 
7.30 – 7.19 (m, 3H), 5.72 – 5.55 (m, 1H), 3.46 (dd, J = 13.2, 5.0 Hz, 1H), 3.32 
(dd, J = 13.2, 6.4 Hz, 1H) ppm 
13C NMR (126 MHz, CDCl3): δ = 169.9, 148.5, 133.8, 133.6, 129.5, 129.2, 
129.0, 127.7, 126.6, 125.7, 122.4, 79.1, 31.8 ppm 
2-((Phenylselanyl) methyl)-1-tosylindoline (57) 
Compound 57 was synthesised following GP2 as a yellow solid. It was 
purified by column chromatography on silica gel using hexane/ethyl 
acetate (4:1) to obtain 87 mg (33% yield). The spectral data are in 
agreement with literature.26 
m.p. = 70 – 72 ºC 
1H NMR (500 MHz, CDCl3): δ = 7.65 (d, J = 8.1 Hz, 1H), 7.61 – 7.54 (m, 2H), 
7.39 – 7.29 (m, 5H), 7.23 – 7.18 (m, 1H), 7.11 – 7.08 (m, 2H), 7.04 – 7.01 
(m, 2H), 4.36 – 4.11 (m, 1H), 3.65 (dd, J = 12.5, 3.5 Hz, 1H), 2.96 – 2.81 (m, 
3H), 2.32 (s, 3H) ppm 
13C NMR (126 MHz, CDCl3): δ = 144.0, 141.4, 134.7, 132.6, 131.1, 129.7, 
129.4, 128.9, 127.9, 127.2, 127.1, 125.3, 124.8, 117.1, 61.7, 34.2, 33.2, 21.6 
ppm 
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